Phibro Animal Health PAHC Amortization expense related to capitalized debt issuance costs
Amortization expense related to capitalized debt issuance costs at other companies
Other financials
Where this comes from
Reported directly by Phibro Animal Health in its filing.
Tagged under the XBRL concept us-gaap:AmortizationOfFinancingCosts.
The official record: Phibro Animal Health’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Phibro Animal Health's amortization expense related to capitalized debt issuance costs.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Phibro Animal Health's amortization expense related to capitalized debt issuance costs?
- Phibro Animal Health (PAHC) reported amortization expense related to capitalized debt issuance costs of $572K in Q1 2026.
- How has Phibro Animal Health's amortization expense related to capitalized debt issuance costs changed year-over-year?
- Phibro Animal Health's amortization expense related to capitalized debt issuance costs decreased by 0.0% year-over-year, from $572K to $572K.
- What is the long-term trend for Phibro Animal Health's amortization expense related to capitalized debt issuance costs?
- Over 4 years (2021 to 2025), Phibro Animal Health's amortization expense related to capitalized debt issuance costs has grown at a 24.7% compound annual growth rate (CAGR), from $833K to $2.02M.